NEW OPPORTUNITIES FOR THERAPY OF UNCONTROLLED ARTERIAL HYPERTENSION
Keywords:
uncontrolled arterial hypertension, excess weight, blood pressure, daily blood pressure monitoringAbstract
Despite numerous studies and achievements in the treatment of arterial hypertension, arterial hypertension remains the world's number one killer and its complications are one of the medical and socio-economic problems, as they lead to increased disability and reduced work capacity of these patients. Keeping especially uncontrolled arterial hypertension under control and preventing the development of its complications is currently one of the pressing problems of cardiologists and primary care physicians.
References
Agababyan R. Irina, Yusupova K. Zumrad. Possibilities of arterial hypertension control in overweight persons // Journal of Biomedicine and practice. 2023, vol. 8, issue 3, pp.246-251
Campana E., Cunha V., Glaveckaite S., Gruev I., Lamirault G., Lehmann E., Masi S., Mfeukeu Kuate L., Mishshenko L., Ona D.I.D., Oo M.Z., TautuO.G.F., Vachulova A., Vintila A.M., Wolf J., Zvartau N., Narkiewicz K., Laurent S. The use of single-pill combinations as first-line treatment for hypertension: translating guidelines into clinical practice. J Hypertens 2020 Aug 21. doi: 10.1097/HJH.0000000000002598.
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environ- mental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1923—1994. doi: 10.1016/ S0140-6736(18)32225-6.
Muntner P., Hardy S.T., Fine L.J., Jaeger B.C., Wozniak G., Levitan E.B., Colantonio L.D. Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018. JAMA 2020;324:1190— 1200. doi: 10.1001/jama.2020.14545.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 populationbased measurement studies with 19•1 million participants. Lancet 2017;389(10064):37—55. doi: 10.1016/S0140-6736(16)31919-5. Erratum in: Lancet 2020;396(10255):886.
Unger T., Borghi C., Charchar F., Khan N.A., Poulter N.R., Prabhakaran D., Ramirez A., Schlaich M., Stergiou G.S., Tomaszewski M., Wainford R.D., Williams B., Schutte A.E. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020;75:1334— 1357. doi: 10.1161/HYPERTENSIONAHA.120.15026.
Vaduganathan M., Claggett B.L., Juraschek S.P., Solomon S.D. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Cardiol 2020;5:576—581. doi: 10.1001/jamacardio.2019.6192.
Y. Wang, X. Nie, L. Chen [et al.]. urden of hypertension in China over the past decades: Systematic analysis of prevalence, treatment and control of hypertension / Y. Wang, X. Nie, L. Chen [et al.]. // European Journal of Preventive Cardiology. - 2015. - Vol. 23, № 8. -P. 792-800.]
Whelton S.P., McEvoy J.W., Shaw L., Psaty B.M., Lima J.A.C., Budoff M., Nasir K., Szklo M., Blumenthal R.S., Blaha M.J. Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors. JAMA Cardiol 2020;5:1011—1018. doi: 10.1001/jamacardio.2020.1731.
Williamson J.D., Supiano M.A., Applegate W.B., Berlowitz D.R., Campbell R.C., Chertow G.M., Fine L.J., Haley W.E., Hawfield A.T., J.H., Kitzman D.W., Kostis J.B., Krousel-Wood M.A., Launer L.J., Oparil S., Rodriguez C.J., Roumie C.L., Shorr R.I., Sink K.M., Wadley V.G., Whelton P.K., Whittle J., Woolard N.F., Wright J.T. Jr, Pajewski N.M.; SPRINT Research Group. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. JAMA 2016;315:2673—2682. doi: 10.1001/jama.2016.7050.
World Health n-Publication Data, Geneva:Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2012; 23:1296-1310
Агабабян Ирина Рубеновна and Юсупова Зумрад Кадамбоевна 2023. ВОЗМОЖНОСТИ ЭФФЕКТИВНОГО КОНТРОЛЯ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ У ЛИЦ С ИЗБЫТОЧНОЙ МАССОЙ ТЕЛА. Research Focus International Scientific Journal. 2, 6 (Jul. 2023), 269–274.
Аляви А.Л., Камилова У.К., Расулова З.Д. Диагностика и лечение ХСН (монография). Тошкент. 2016.
Бадритдинова, М. Н. Распространенность некоторых компонентов метаболического синдрома среди женского населения / М. Н. Бадритдинова, Д. Ш. Кудратова, Д. А. Очилова // Биология и интегративная медицина. - 2016. - № 2. - С. 53-61.
Козловский В.И., Симанович А.В. Вестник ВГМУ, 2014, Т. 13 (2):6-16
Качковский, М. А. Возрастные и гендерные показатели распространенности артериальной гипертонии в Промышленном районе города Самары / М. А. Качковский, И. С. Федосеева, Л. М.Назаркина // Дневник Казанской медицинской школы. - 2016. - № 1(11). -С. 11-13.
Сборник статистических показателей достижения национальных ЦУР в Республике Узбекистан. – Ташкент: Государственный комитет Республики Узбекистан по статистике, 2020 – C.49-58.
